Patent · US Expired

Isoxazolopyridinones

US7087756B2 · kind B2 · utility

4Cited by

5References

2Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Samuel Hintermann · Basel, CH
Bastian Hengerer · Ulm, DE
Ulrike Von Krosigk · Basel, CH

Key dates

Filing date	Aug 14, 2002
Grant date	Aug 8, 2006
Priority date	—
Expiry date	Aug 14, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of formula I, wherein X, Y, R1, R2, and R3 are as defined in the description, and the preparation thereof. The compounds of formula I are useful as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.